Keywords
Patent Requirements
Pharmaceutical products
Medicines
Andean Communitarian Law
Free Trade Agreement Colombia–USA
Free Trade Agreement Colombia–UE
trips Agreement
How to Cite
Abstract
Patent protection law for pharmaceutical products and medicines must har- monize the interests of both pharmaceutical industry and public health. Any pharmaceutical product must fulfill the requirements established by law to be registered as a patent. In the Andean Community, communitarian law gives preference to local law even if it comes from national sources or international treaties. Free Trade Agreements between Colombia and the United States of America, or Colombia and the European Union recognize the principles of domestic treatment and most favored nation. These agreements also create uniform legislation on patents and establish some instruments to limit the rights of inventors in few cases that involve public health interests.
This article is the result of a study made by the author at La Sabana University under the project: “Transformation on Liability in Colombian legislation after the approval of the Trade Agreements between Colombia and the European Union, and between Colombia and the United States of America – Intellec- tual Property Chapter”. Several resources such as history, judicial decisions, author’s opinions a comparative law were used.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.